S100B and mood disorder: We present a comprehensive study aimed at identifying the causal effects of circulating S100B levels on six neuropsychiatric or neurological disorders, including neurodevelopmental (ASD and SCZ), neurodegenerative (AD and PD), and mood disorders (BIP and MDD).